cancer genetics inc (CGIX:NASDAQ CM)
Andrew D. Zelenetz M.D., Ph.D.
Member of Scientific Advisory Board, Cancer Genetics, Inc.
|Age||Total Calculated Compensation||This person is connected to 20 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Dr. Andrew D. Zelenetz, M.D., Ph.D serves as Head of the Molecular Hemo-oncology Laboratory in the Department of Medicine of MSKCC. Dr. Zelenetz joined MSKCC in 1991. Dr. Zelenetz serves as Vice Chairman of Medical Informatics, Dept of Medicine, Memorial Sloan-Kettering Cancer Center and Associate Professor of Medicine at Weill Medical College, Cornell University. He served as Chief of Lymphoma Service, Division at Hematology/Oncology at MSKCC from 1994 to 2013. Dr. ...
201 Route 17 NorthPhone: 201-528-9200
Rutherford, New Jersey 07070
Board Members Memberships*There is no Board Members Memberships data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Douglas M. VanOort||Executive Chairman and Chief Executive Officer|
|Kenneth A. Berlin||Chief Executive Officer and President|
Rosetta Genomics, Ltd.
|Thomas A. Bologna||Chairman and Chief Executive Officer|
Response Genetics, Inc
|Michael J. Pellini M.D., MBA||Chief Executive Officer and Director|
Foundation Medicine, Inc.
|Samuel D. Riccitelli||Chief Executive Officer, President and Director|
Signal Genetics, Inc.
|$540.0K||Compensation as of Fiscal Year 2014.|